#bones

Lessons learned during the global scale-up of HIV treatment can be used to address epidemics of TB and non-communicable diseases (NCDs).

People living with HIV and hepatitis C virus (HCV) coinfection are more likely to experience a hip fracture as a result of decreased bone mine...

Compared with people living with HIV and not being treated for it, those using antiretroviral (ARV) therapy are less likely to experience...

Two annual doses of Reclast (zoledronate) improved bone health for up five years in a small study involving HIV-positive people with bone mine...

Vitamin D supplementation may help prevent hormonal changes that can lead to bone loss among adolescents and young adults being treated for HI...

People living with or at risk for cardiovascular disease should consider vitamin D supplementation, despite limits in supporting data.

For people living with HIV on public health insurance, the risk of dying is about twice that of those who have private health insurance.

Compared with the nucleoside analog abacavir, tenofovir is more likely to increase levels of a hormone responsible for regulating calcium in t...

Truvada (tenofovir plus emtricitabine) was associated with greater bone loss than Epzicom (abacavir plus lamivudine), according to a study pub...

HIV-positive people who have low CD4 counts are at much higher risk of fragility fractures than people with higher CD4 counts, according to a...